Description

5H-Cyclohepta[B]Pyridin-9-Ol,4-Ethoxy-6,7,8,9-Tetrahydro-(9Ci) is a complex heterocyclic organic compound of significant interest in advanced chemical synthesis. This specialized intermediate is valued for its unique fused-ring structure, which serves as a critical building block in the development of novel pharmacologically active molecules. It is primarily sought by research institutions and pharmaceutical companies engaged in the discovery and development of new therapeutic agents, particularly within medicinal chemistry and process research.

Application

• Pharmaceutical Intermediate: A key synthetic precursor in the research and development of new drug candidates, particularly for central nervous system (CNS) and other therapeutic areas.
• Medicinal Chemistry Research: Used as a sophisticated scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• Process Chemistry Development: Serves as a critical intermediate in scaling up synthetic routes for Active Pharmaceutical Ingredients (APIs) under Good Manufacturing Practice (GMP) conditions.
• Academic & Institutional Research: Employed in universities and research institutes for studying novel heterocyclic reactions and synthesizing complex molecular libraries.
• Contract Research & Manufacturing (CRO/CMO): Supplied to service organizations supporting the pharmaceutical industry with custom synthesis and scale-up capabilities.

Basic Information

Product Name	5H-Cyclohepta[B]Pyridin-9-Ol,4-Ethoxy-6,7,8,9-Tetrahydro-(9Ci)
CAS No.	171077-46-6
Molecular Formula	C14H19NO2
Molecular Weight	233.31 g/mol
Synonyms	4-Ethoxy-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-ol; 9H-Cyclohepta[b]pyridin-9-ol, 4-ethoxy-6,7,8,9-tetrahydro-; 4-Ethoxy-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-one (tautomer); 171077-46-6; Tetrahydro-4-ethoxy-5H-cyclohepta[b]pyridin-9-ol; 5H-Cyclohepta[b]pyridin-9-ol, 4-ethoxy-6,7,8,9-tetrahydro-
EINECS	Contact for details

Quality Control

Our 5H-Cyclohepta[B]Pyridin-9-Ol,4-Ethoxy-6,7,8,9-Tetrahydro-(9Ci) is produced under strict quality management systems to ensure batch-to-batch consistency and high purity for research and development applications. We provide comprehensive analytical data, including HPLC purity, identity confirmation (IR, NMR), and residual solvent analysis. Certificates of Analysis (COA) are available for every batch and supplied upon request to support your regulatory and quality documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep away from heat, sparks, and open flame. For long-term storage, consider storage under an inert atmosphere to maintain product integrity.

Specification

Item	Specification
Appearance	White to off-white powder or crystalline solid
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 0.5%
Residual Solvents (GC)	Meets ICH guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.